Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis

Gaya Spolverato1, Hadia Maqsood, Alessandro Vitale

  • 1The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Readmission after liver surgery for intrahepatic cholangiocarcinoma (ICC) affects 1 in 13 patients. Pre-operative jaundice and post-operative complications significantly increase the risk of 30-day readmission.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Intrahepatic cholangiocarcinoma (ICC) is a primary liver cancer.
  • Hepatic resection is a key treatment for ICC.
  • Understanding readmission rates is crucial for patient outcomes.

Purpose of the Study:

  • To determine the incidence of 30-day readmission after hepatic resection for ICC.
  • To identify risk factors associated with readmission in ICC patients.

Main Methods:

  • Retrospective analysis of 602 patients undergoing hepatic resection for ICC.
  • Data collected from 12 international hepatobiliary centers (1990-2013).
  • Examined clinicopathologic factors and 30-day readmission rates.

Main Results:

  • The 30-day readmission rate was 7.8% (47/602 patients).
  • Major hepatectomy was performed in 68.3% of patients.
  • Risk factors for readmission included pre-operative jaundice (OR 2.45) and major post-operative complications (OR 3.38).
  • 95.7% of readmitted patients had complications versus 38.8% of non-readmitted patients.

Conclusions:

  • Readmission after ICC resection occurs in approximately 1 in 13 patients.
  • Pre-operative jaundice and post-operative complications are significant predictors of readmission.
  • Patients with complications face over a threefold higher risk of readmission.
Abstract

Related Concept Videos